C Yuen Ryan K, Merico Daniele, Bookman Matt, L Howe Jennifer, Thiruvahindrapuram Bhooma, Patel Rohan V, Whitney Joe, Deflaux Nicole, Bingham Jonathan, Wang Zhuozhi, Pellecchia Giovanna, Buchanan Janet A, Walker Susan, Marshall Christian R, Uddin Mohammed, Zarrei Mehdi, Deneault Eric, D'Abate Lia, Chan Ada J S, Koyanagi Stephanie, Paton Tara, Pereira Sergio L, Hoang Ny, Engchuan Worrawat, Higginbotham Edward J, Ho Karen, Lamoureux Sylvia, Li Weili, MacDonald Jeffrey R, Nalpathamkalam Thomas, Sung Wilson W L, Tsoi Fiona J, Wei John, Xu Lizhen, Tasse Anne-Marie, Kirby Emily, Van Etten William, Twigger Simon, Roberts Wendy, Drmic Irene, Jilderda Sanne, Modi Bonnie MacKinnon, Kellam Barbara, Szego Michael, Cytrynbaum Cheryl, Weksberg Rosanna, Zwaigenbaum Lonnie, Woodbury-Smith Marc, Brian Jessica, Senman Lili, Iaboni Alana, Doyle-Thomas Krissy, Thompson Ann, Chrysler Christina, Leef Jonathan, Savion-Lemieux Tal, Smith Isabel M, Liu Xudong, Nicolson Rob, Seifer Vicki, Fedele Angie, Cook Edwin H, Dager Stephen, Estes Annette, Gallagher Louise, Malow Beth A, Parr Jeremy R, Spence Sarah J, Vorstman Jacob, Frey Brendan J, Robinson James T, Strug Lisa J, Fernandez Bridget A, Elsabbagh Mayada, Carter Melissa T, Hallmayer Joachim, Knoppers Bartha M, Anagnostou Evdokia, Szatmari Peter, Ring Robert H, Glazer David, Pletcher Mathew T, Scherer Stephen W
The Centre for Applied Genomics, Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada.
Deep Genomics Inc., Toronto, Canada.
Nat Neurosci. 2017 Apr;20(4):602-611. doi: 10.1038/nn.4524. Epub 2017 Mar 6.
We are performing whole-genome sequencing of families with autism spectrum disorder (ASD) to build a resource (MSSNG) for subcategorizing the phenotypes and underlying genetic factors involved. Here we report sequencing of 5,205 samples from families with ASD, accompanied by clinical information, creating a database accessible on a cloud platform and through a controlled-access internet portal. We found an average of 73.8 de novo single nucleotide variants and 12.6 de novo insertions and deletions or copy number variations per ASD subject. We identified 18 new candidate ASD-risk genes and found that participants bearing mutations in susceptibility genes had significantly lower adaptive ability (P = 6 × 10). In 294 of 2,620 (11.2%) of ASD cases, a molecular basis could be determined and 7.2% of these carried copy number variations and/or chromosomal abnormalities, emphasizing the importance of detecting all forms of genetic variation as diagnostic and therapeutic targets in ASD.
我们正在对患有自闭症谱系障碍(ASD)的家庭进行全基因组测序,以建立一个资源库(MSSNG),用于对相关表型和潜在遗传因素进行分类。在此,我们报告了对来自ASD家庭的5205个样本进行测序,并附带临床信息,创建了一个可通过云平台和受控访问互联网门户访问的数据库。我们发现,每个ASD受试者平均有73.8个新生单核苷酸变异以及12.6个新生插入缺失或拷贝数变异。我们鉴定出18个新的ASD风险候选基因,并发现携带易感基因突变的参与者的适应能力显著较低(P = 6×10)。在2620例ASD病例中的294例(11.2%)中,可以确定分子基础,其中7.2%携带拷贝数变异和/或染色体异常,这强调了检测所有形式的遗传变异作为ASD诊断和治疗靶点的重要性。